Market Cap 169.18M
Revenue (ttm) 200.16M
Net Income (ttm) 2.94M
EPS (ttm) N/A
PE Ratio 17.26
Forward PE 12.66
Profit Margin 1.47%
Debt to Equity Ratio 0.00
Volume 34,354
Avg Vol 148,998
Day's Range N/A - N/A
Shares Out 12.59M
Stochastic %K 48%
Beta 0.45
Analysts Strong Sell
Price Target $32.50

Company Profile

LifeVantage Corporation engages in the identification, research, development, formulation, and sale of advanced nutrigenomic activators, dietary supplements, nootropics, pre- and pro-biotics, weight management, and skin and hair care products. It offers Protandim, a dietary supplement; LifeVantage Omega+, a dietary supplement that combines DHA and EPA Omega-3 fatty acids, Omega-7 fatty acids, and vitamin D3; LifeVantage ProBio, a dietary supplement to support gut health; LifeVantage IC Bright, a...

Industry: Packaged Foods
Sector: Consumer Defensive
Phone: 801 432 9000
Address:
3300 North Triumph Boulevard, Suite 700, Lehi, United States
TimRegan_WTR
TimRegan_WTR Aug. 5 at 7:56 PM
0 · Reply
JMAR_WTR
JMAR_WTR Aug. 5 at 7:53 PM
0 · Reply
research_WTR
research_WTR Aug. 5 at 3:13 PM
Check out Douglas M. Lane, CFA's recap from his latest podcast with @lifevantage Corporation CEO Steven R. Fife and CMO Julie Boyster to drill down on the science of nutrigenomics. Those interested can listen to this podcast on Apple Podcasts, Spotify, or on our website. Links are accessible in our full report! https://www.watertowerresearch.com/doc?docID=UR_LFVN_08022025 $LFVN #Podcast #SmallCap #Spotlight #Stocks #Investing #WeightLoss #GLP1 #Health #Healthcare #MindBody
0 · Reply
TimRegan_WTR
TimRegan_WTR Aug. 4 at 10:22 PM
0 · Reply
JMAR_WTR
JMAR_WTR Aug. 4 at 7:09 PM
0 · Reply
research_WTR
research_WTR Aug. 4 at 6:57 PM
WTR Small-Cap Spotlight: #139 In our latest episode, WTR's Tim Gerdeman & Douglas M. Lane, CFA talk with LifeVantage Corporation (NASDAQ: LFVN) CEO Steven R. Fife and CMO Julie Boyster about: 🔹 Nutrigenomics: How nutrients influence your genes. 🔹 MindBody GLP-1 System: New clinical insights into LifeVantage’s patent-pending formulation. 🔹 Powerful Synergies: Combining MindBody with their flagship Nrf2 Synergizer for amplified health benefits. Dive into the science behind gene activation and wellness innovation. 🎧 Listen now! Apple: https://podcasts.apple.com/us/podcast/lifevantage-ceo-steve-fife-and-cmo-julie-boyster-on/id1693448305?i=1000720626717 Spotify: https://open.spotify.com/episode/361T7mOWuWWqJlT27jEl8g?si=cc6ee3a581604454 Website: https://www.watertowerresearch.com/media-detail/2274/Media Others: https://pod.link/1693448305 $LFVN #LifeVantage #Nutrigenomics #HealthInnovation #SmallCapSpotlight #SmallCap #Podcast #Stocks #Investing #WaterTowerResearch
0 · Reply
Pitoentuboca
Pitoentuboca Jul. 14 at 5:41 PM
$LFVN excellent back to $13 $$$$$$$
0 · Reply
Pitoentuboca
Pitoentuboca Jul. 10 at 6:18 PM
$LFVN IM IN RIGHT HERE $$$$$
0 · Reply
Pitoentuboca
Pitoentuboca Jun. 23 at 3:48 PM
$LFVN DOUBEL DOWN HERE WHAT HAPPENED $$$$
0 · Reply
Pitoentuboca
Pitoentuboca Jun. 23 at 2:39 PM
$LFVN LOOKS GOOD HERE $$$11.85 I TRILLION SHARES $$$
0 · Reply
Latest News on LFVN
LifeVantage To Open Iceland Market

Jul 24, 2025, 8:00 AM EDT - 14 days ago

LifeVantage To Open Iceland Market


The LifeVantage Advantage: High Retention, High Returns

Jul 21, 2025, 5:48 AM EDT - 17 days ago

The LifeVantage Advantage: High Retention, High Returns


LifeVantage Corporation (LFVN) Q3 2025 Earnings Call Transcript

May 6, 2025, 9:09 PM EDT - 3 months ago

LifeVantage Corporation (LFVN) Q3 2025 Earnings Call Transcript


LifeVantage Declares Quarterly Dividend

May 6, 2025, 4:06 PM EDT - 3 months ago

LifeVantage Declares Quarterly Dividend


LifeVantage: Activation Of Shareholder Value

May 5, 2025, 7:15 AM EDT - 3 months ago

LifeVantage: Activation Of Shareholder Value


LifeVantage: Post-Earnings Selloff Provides Buying Opportunity

Feb 6, 2025, 12:06 PM EST - 6 months ago

LifeVantage: Post-Earnings Selloff Provides Buying Opportunity


LifeVantage Corporation (LFVN) Q2 2025 Earnings Call Transcript

Feb 5, 2025, 8:38 PM EST - 6 months ago

LifeVantage Corporation (LFVN) Q2 2025 Earnings Call Transcript


LifeVantage to Participate in the 27th Annual ICR Conference

Jan 6, 2025, 4:05 PM EST - 7 months ago

LifeVantage to Participate in the 27th Annual ICR Conference


Top 2 Defensive Stocks That May Crash In Q1

Jan 6, 2025, 7:49 AM EST - 7 months ago

Top 2 Defensive Stocks That May Crash In Q1

ODC


Top 3 Risk Off Stocks That May Collapse This Month

Dec 20, 2024, 8:54 AM EST - 8 months ago

Top 3 Risk Off Stocks That May Collapse This Month

NAPA PAVS


LifeVantage Corporation (LFVN) Q1 2025 Earnings Call Transcript

Oct 29, 2024, 9:49 PM EDT - 10 months ago

LifeVantage Corporation (LFVN) Q1 2025 Earnings Call Transcript


LifeVantage To Participate in Upcoming Investor Conferences

May 23, 2024, 8:00 AM EDT - 1 year ago

LifeVantage To Participate in Upcoming Investor Conferences


LifeVantage Appoints Dayton Judd to the Board of Directors

Feb 15, 2024, 4:05 PM EST - 1 year ago

LifeVantage Appoints Dayton Judd to the Board of Directors


TimRegan_WTR
TimRegan_WTR Aug. 5 at 7:56 PM
0 · Reply
JMAR_WTR
JMAR_WTR Aug. 5 at 7:53 PM
0 · Reply
research_WTR
research_WTR Aug. 5 at 3:13 PM
Check out Douglas M. Lane, CFA's recap from his latest podcast with @lifevantage Corporation CEO Steven R. Fife and CMO Julie Boyster to drill down on the science of nutrigenomics. Those interested can listen to this podcast on Apple Podcasts, Spotify, or on our website. Links are accessible in our full report! https://www.watertowerresearch.com/doc?docID=UR_LFVN_08022025 $LFVN #Podcast #SmallCap #Spotlight #Stocks #Investing #WeightLoss #GLP1 #Health #Healthcare #MindBody
0 · Reply
TimRegan_WTR
TimRegan_WTR Aug. 4 at 10:22 PM
0 · Reply
JMAR_WTR
JMAR_WTR Aug. 4 at 7:09 PM
0 · Reply
research_WTR
research_WTR Aug. 4 at 6:57 PM
WTR Small-Cap Spotlight: #139 In our latest episode, WTR's Tim Gerdeman & Douglas M. Lane, CFA talk with LifeVantage Corporation (NASDAQ: LFVN) CEO Steven R. Fife and CMO Julie Boyster about: 🔹 Nutrigenomics: How nutrients influence your genes. 🔹 MindBody GLP-1 System: New clinical insights into LifeVantage’s patent-pending formulation. 🔹 Powerful Synergies: Combining MindBody with their flagship Nrf2 Synergizer for amplified health benefits. Dive into the science behind gene activation and wellness innovation. 🎧 Listen now! Apple: https://podcasts.apple.com/us/podcast/lifevantage-ceo-steve-fife-and-cmo-julie-boyster-on/id1693448305?i=1000720626717 Spotify: https://open.spotify.com/episode/361T7mOWuWWqJlT27jEl8g?si=cc6ee3a581604454 Website: https://www.watertowerresearch.com/media-detail/2274/Media Others: https://pod.link/1693448305 $LFVN #LifeVantage #Nutrigenomics #HealthInnovation #SmallCapSpotlight #SmallCap #Podcast #Stocks #Investing #WaterTowerResearch
0 · Reply
Pitoentuboca
Pitoentuboca Jul. 14 at 5:41 PM
$LFVN excellent back to $13 $$$$$$$
0 · Reply
Pitoentuboca
Pitoentuboca Jul. 10 at 6:18 PM
$LFVN IM IN RIGHT HERE $$$$$
0 · Reply
Pitoentuboca
Pitoentuboca Jun. 23 at 3:48 PM
$LFVN DOUBEL DOWN HERE WHAT HAPPENED $$$$
0 · Reply
Pitoentuboca
Pitoentuboca Jun. 23 at 2:39 PM
$LFVN LOOKS GOOD HERE $$$11.85 I TRILLION SHARES $$$
0 · Reply
TimRegan_WTR
TimRegan_WTR May. 29 at 5:31 PM
0 · Reply
research_WTR
research_WTR May. 29 at 5:21 PM
Read Doug Lane's recap and transcript follow his fireside chat with @lifevantage CEO Steven R. Fife and CFO Carl Aure discussing recent results, including the international rollout of LFVN’s new MindBody GLP-1 System. This conversation can be accessed on demand. A link is accessible in our full report! https://www.watertowerresearch.com/doc?docID=MS_LFVN_05212025 $LFVN #LifeVantage #Consumer #MindBody #GLP1 #WeightLoss #SmallCap #Stocks #Invetsing #WTRInsights
0 · Reply
TimRegan_WTR
TimRegan_WTR May. 8 at 6:00 PM
0 · Reply
research_WTR
research_WTR May. 8 at 5:58 PM
LifeVantage (LFVN) beat EPS expectations in F3Q25 with $0.26 vs. $0.19 est., up 23.8% Y/Y, driven by strong demand for its MindBody GLP-1 System. 🔹 Revenue rose 21.1% to $58.4M, slightly below forecast 🔹 Customer count dipped post-launch, but consultant retention held steady 🔹 Adjusted EBITDA of $6.4M beat expectations, boosted by lower incentives 🔹 International MindBody rollout began in March, expected to drive F4Q growth Subscribe at our website to follow along with Doug Lane! https://www.watertowerresearch.com/doc?docID=UR_LFVN_05072025 $LFVN
0 · Reply
ScubaTrading
ScubaTrading May. 8 at 2:41 PM
$LFVN that’s it for me. I’m out! Thanks for the run!
0 · Reply
QuantInsider
QuantInsider May. 8 at 2:24 AM
What’s the scoop with $LFVN? I've seen some chatter about options trading picking up more than usual—definitely worth raising an eyebrow. You know, when the big players start making moves, it can mean there’s more than meets the eye. I often check in on InsiderFinance to see what they’re saying; they seem to have a knack for spotting trends early. So, is this just a flash in the pan or could something bigger be brewing under the surface? Any thoughts from the crew?
0 · Reply
ScubaTrading
ScubaTrading May. 7 at 6:03 PM
$LFVN It’s about time!!!
1 · Reply
MaverikIT
MaverikIT May. 7 at 4:49 PM
$LFVN $BRBR - dietary supplements & proteins to the dumpsters
0 · Reply
ScubaTrading
ScubaTrading May. 7 at 2:21 PM
$LFVN accumulating….
0 · Reply
thinkandpick
thinkandpick Apr. 29 at 9:38 AM
$MED $XRT $WGHW $LFVN $HLF Medifast's (MED) cash and investments are $165 million at the end of Q1 2025, while debt remains ZERO:https://www.businesswire.com/news/home/20250428625142/en/Medifast-Announces-First-Quarter-2025-Financial-Results In other words, despite the revenue YoY drop, MED generated positive operating cash flow and positive free cash flow for another quarter in a row, so its cash and investments went up sequentially. Its cash and investments were $162 million at the end of Dec 2024.
0 · Reply
badtrader21642
badtrader21642 Apr. 14 at 12:04 PM
$LFVN PFIZER $PFE IS STOPPING THE DEVELOPMENT OF ITS WEIGHT-LOSS PILL
0 · Reply
Doozio
Doozio Apr. 13 at 11:39 PM
$LFVN 3wt bahhhhtom of base sitting on 200d. Stay young waiting in Roger!
0 · Reply